Dashenlin Pharm Grp Co Ltd (603233) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.096x

Based on the latest financial reports, Dashenlin Pharm Grp Co Ltd (603233) has a cash flow conversion efficiency ratio of 0.096x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥818.72 Million ≈ $119.80 Million USD) by net assets (CN¥8.49 Billion ≈ $1.24 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603233 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Dashenlin Pharm Grp Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Dashenlin Pharm Grp Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Dashenlin Pharm Grp Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dashenlin Pharm Grp Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Vidrala SA MC:VID	0.153x
ArcBest Corp NASDAQ:ARCB	0.007x
CCC S.A. WAR:CCC	0.290x
California Water Service Group NYSE:CWT	0.098x
Gold Road Resources Ltd AU:GOR	0.122x
Viscofan MC:VIS	0.066x
Companhia de Gás de São Paulo - COMGÁS SA:CGAS3	0.555x
Shanghai Hanbell Precise Machinery Co Ltd SHE:002158	0.046x

Annual Cash Flow Conversion Efficiency for Dashenlin Pharm Grp Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Dashenlin Pharm Grp Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Dashenlin Pharm Grp Co Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.66 Billion ≈ $1.27 Billion	CN¥5.35 Billion ≈ $782.90 Million	0.618x	+61.83%
2024-12-31	CN¥8.14 Billion ≈ $1.19 Billion	CN¥3.11 Billion ≈ $454.55 Million	0.382x	-4.60%
2023-12-31	CN¥7.93 Billion ≈ $1.16 Billion	CN¥3.17 Billion ≈ $464.43 Million	0.400x	-26.90%
2022-12-31	CN¥6.86 Billion ≈ $1.00 Billion	CN¥3.76 Billion ≈ $549.70 Million	0.547x	+108.91%
2021-12-31	CN¥5.94 Billion ≈ $868.61 Million	CN¥1.55 Billion ≈ $227.54 Million	0.262x	-25.28%
2020-12-31	CN¥5.57 Billion ≈ $815.49 Million	CN¥1.95 Billion ≈ $285.92 Million	0.351x	-11.07%
2019-12-31	CN¥4.33 Billion ≈ $633.86 Million	CN¥1.71 Billion ≈ $249.90 Million	0.394x	+39.29%
2018-12-31	CN¥3.09 Billion ≈ $451.68 Million	CN¥873.64 Million ≈ $127.84 Million	0.283x	+23.87%
2017-12-31	CN¥2.80 Billion ≈ $410.12 Million	CN¥640.39 Million ≈ $93.71 Million	0.228x	-38.12%
2016-12-31	CN¥1.34 Billion ≈ $196.39 Million	CN¥495.60 Million ≈ $72.52 Million	0.369x	-19.52%
2015-12-31	CN¥1.02 Billion ≈ $149.43 Million	CN¥468.59 Million ≈ $68.57 Million	0.459x	-41.20%
2014-12-31	CN¥574.85 Million ≈ $84.12 Million	CN¥448.58 Million ≈ $65.64 Million	0.780x	+59.72%
2013-12-31	CN¥589.93 Million ≈ $86.32 Million	CN¥288.22 Million ≈ $42.18 Million	0.489x	-35.64%
2012-12-31	CN¥381.11 Million ≈ $55.77 Million	CN¥289.31 Million ≈ $42.34 Million	0.759x	--

About Dashenlin Pharm Grp Co Ltd

SHG:603233 China Pharmaceutical Retailers

Market Cap

$2.69 Billion

CN¥18.39 Billion CNY

Market Cap Rank

#5350 Global

#1029 in China

Share Price

CN¥16.15

Change (1 day)

+0.50%

52-Week Range

CN¥15.79 - CN¥21.27

All Time High

CN¥57.53